DDS^® PLUS: contains 5 billion viable DDS-strain Lactobacillus acidophilus, Bifidus and FOS (100mg) per gram in a rice starch base. DDS^® PLUS should be kept refrigerated. DDS^® PLUS does not contain monosodium glutamate (MSG) soy, wheat or dairy (it is hypoallergenic). 100 capsules per bottle.

NUtrITION INFORMATION: Microorganisms that inhabit our skin and mucus membranes establish a miniature ecosystem with our bodies to maintain health and well being. Although the microflora ecosystem is generally stable, it is sensitive to certain factors. In such cases, the normal flora may be replaces by toxin-producing or pathogenic bacteria that may be associated with all manner of acute symptoms and/or chronic generative disease. Numerous factors can adversely affect the microflora ecosystem, including:

1. The use of broad spectrum antibiotics
2. Dietary factors including meats from animals given antibiotics
3. Imporper fiber intake causing gastrointestinal disturbances
4. Fruits and vegetables which often contain residues from pesticides and herbicides
5. Pathogeninc mocroorganisms- an otherenvironmental factors which adversely affect the microflora

When toxin-producing or pathogenic bacteria inhabit the intestine, wide-ranges of effects occur. Several manifestations of these ocurrences are listed in Table 1.

L. acidophilus, L. Bifidus (Bifidus longum), and FOS are all normal inhabitants of the human intestinal tract, and are ususlly considered for dietary supplementation. The qualities possessed by bacteria used for dietary supplementation are:

1. They should be normal inhabitants of the host intestine or be capable of adapting to the host intestinal environment (e.g. bile resistance).
2. They must survive passage into the intestine and be capable of establishing in the intestine, particularly the small intestine where physiological activities associated with digestion and absoption of nutrients would be expected to occur.
3. They must perform functions that are advantageous to the host.

To emphasize the importance of a balanced microbial population in the healthy intestine, UAS Laboratories has combined these heathful microorganisms into one product. Microorganisms, like nutrients, work in concert. By combining these heathful microorganisms into one product, DDS Plus is a broad-spectrum product providing the complete picture of intestinal microbial protection.

DDS^® PLUS: is a complete microorganism supplement for the intestine.

No specific claim is made for this nutritional preparation. Any recommendations for its use are based soley upon the discretion of the doctor. The information contained within is based upon authorative and reliable source. As such, disagreement is possible.

What makes DDS-1 the

powerful acidophilus?

DDS-1. One Probiotic. So many uses. So much clinical validation.

What are the important aspects of DDS-1? Why is DDS-1 considered to be one of the most reliable, safest, and effective of all probiotic products today?

The first of two reports will give you insight about how DDS-1 acidophilus works and why it is beneficial to make this a part of your diet.

You’ve probably seen the DDS-1 name at your local health food store. No, this is not some miracle drug, but, rather, a friendly bacteria known to most of us as Lactobacillus acidophilus. While there are many different varieties of beneficial probiotic bacteria being sold today, DDS-1 is considered to be one of the most important because of its long-standing scientific validation and proven ability to colonize in the human gastrointestinal tract.

Studies illustrate that DDS-1 can lower cholesterol and relieve gastrointestinal (GI) tract dis orders like diarrhea as well as improve digestion. DDS-1 even contains a highly unique and potent antibacterial substance, as well as demonstrating cholesterol-lowering and anticancer effects.

BENEFICIAL BACTERIA:

GI JOES OF YOUR GI TRACT

To better understand the principles of beneficial probiotics, gut health can be likened to maintaining your front lawn. L. acidophilus bacteria represent healthy green grass, while Candida albicans and E. coli are weeds threatening to overcome the former L. acidophilus keeps these weeds in check.

According to Natural Products Industry Insider writer Heather Granato, the digestive tract contains more than 100 trillion bacteria that altogether weigh four pounds. The 400 to 500 strains of bacteria within this group form the front line against invading organisms and help the gastrointestinal tract absorb nutrients and maintain overall wellness. In addition, L. acidophilus and related beneficial bacterial strains help the absorption of calcium, copper, iron, and magnesium. They also help the body to produce B-complex vitamins as well as vitamin K.

THE HISTORY OF DDS-1

Yet, there is a particular strain of L. acidophilus that requires special attention – DDS-1. It is taken from the strain found in our bodies, and therefore may be the reason why it survives very well both the acid and basic portion of our gastrointestinal tract. DDS-1 has been heralded as the ultimate probiotic; it is backed by U.S. patent, with its antibacterial and anticarcinogenic properties extremely well documented. Khem M. Shahanti, Ph.D., researched the DDS-1 strain Lactobacillus acidophilus at the University of Nebraska in 1959 and named it after the Department of Dairy Science (hence the DDS suffix).

For more than 25 years, Lactobacillus acidphiilus DDS-1 strain has been marketed commercially worldwide as an effective probiotic strain. It has been the subject of a variety of in vitro, human and animal studies for more than 40 years. The focus of the efficacy research on this strain has been on its nutritional, antibacterial and anti-pathogenic, anti-carcinogenic and technological properties of DDS-1 have been studied.

STABILITY OF DDS-1

O f course, for probiotics to be of any use, they need to retain potency. With the incorporation of a patented technology from the University of Wisconsin, DDS-1 can remain stable for up to two years. Stability of DDS-1 was tested. DDS-1 can remain stable for up to two years. Stability of DDS-1 was tested. DDS-1 was combined with Bifidobacterium longum at equal ratio and fortified with fructooligosaccharide at a five percent rate. This supplement calld DDS-Plus was tested for potency every month for 12 months using the Standard Methods for Dairy Products. The stability curve shows that L. acidophilus DDS-1 is very stable and the loss of potency was about seven percent in one year.

NUTRITIONAL BENEFITS OF DDS-1

Laboratory and clinical trials have shown the importance of maintaining a healthy level of L. acidophilus for overall health. And DDS-1 is known to work extremely well, which is why it is one of America’s leading probiotic lines and sought after by savvy, knowledgeable consumers who are interested in both value and quality

ANTIBACTERIAL EFFECTS

A compound with antibacterial properties is produced by DDS-1. Named “acidophilin,” this compound was isolated from milk in which DDS-1 was grown. Other L. acidophilus strains did not produce significant amounts of this compound. Acidophilin fractions were concentrated and tested against some common food-borne pathogens where it was shown to inhibit Clostridium botulinum, Clostridium perfringens, Escherichia coli, Proteus mirabilis, Salmonella enteritidis, Salmonella typhiurium, Staphylococcus aureus, and Staphylococcus faecalis. As an important follow up to this in vitro demonstration of activity, additional studies demonstrated the effectiveness of acidophilus milk on decreasing the carrier state and on the incidence and duration of salmonella and shigella dysentery in children.

The ability of DDS-1 to inhibit Staphylococcus auereus was further demonstrated. S. auereus growth was inhibited in acidophilus yogurt, likely due to a combination of activity of hydrogen peroxide, lactic acid and bacteriocin.

Against H. pylori

More recently, researchers have reported the ability of DDS-1 to inhibit in a co-culter assay Helicobacter pylori, the bacterium though to be responsible for ulcers.

Against UTIs

There is growing evidence suggesting that probiotics can be effective in the prevention of recurrent urinary tract infection (UTI). The proposed mechanism of action includes the inhibition of growth and adhesion of pathogens to the vaginal and urethral mucosa (inner lining). In a case study, L. acidophilus DDS-1 with two billion viable organisms was given twice daily for a month and followed up with once daily to patients. It showed positive effects.

Against Candida albicans

In a case study at a primary health care clinic, DDS-1 was given to 42 patients for a period of three months, 22 of whom reported improvement in levels of Candida albicans.

LOWERING CHOLESTEROL

The cholesterol-lowering effect of DDS-1 was first investigated in 1978 by D.K. Sinha. He observed that adding four million L. acidophilus DDS-1 was shown to have a higher protein digestibility than heated milk when tested in rats.